PMS-IRBESARTAN-HCTZ
PMS-IRBESARTAN-HCTZ
Approved
DIN Number
02328534
Drug Class
Human
Market Date
Mar 24, 2011
Company
HC
Pharmascience Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02328534
AIG Number0240086003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09DA04 IRBESARTAN AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.08
Health Canada Classification
ACTIVE INGREDIENTS (2)
HYDROCHLOROTHIAZIDEActive
Strength: 25 MG
Monograph: HYDROCHLOROTHIAZIDE
IRBESARTANActive
Strength: 300 MG
Monograph: IRBESARTAN